Health Research Methods, Evidence, and Impact


Kaitryn Campbell

MLIS (Western), BEd (Queens)

Assistant Professor (Part-time), Dept of Health Research Methods, Evidence, and Impact

kcampbe@mcmaster.ca

 

 

 



Academic Interests

Ms. Campbell's research interests include information retrieval and management for the purposes of economic evaluation and health technology assessment.

Selected Publications

 

  1. Blackhouse G, Xie F, Levine MA, Campbell K, Assasi N, Gaebel K, O'Reilly D, Tarride J, Goeree R. Canadian cost-utility analysis of intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura. J Popul Ther Clin Pharmacol 2012;19(2):e166-78.
  2. Blackhouse G, Assasi N, Xie F, Marshall J, Irvine EJ, Gaebel K, Campbell K, Hopkins R, O'Reilly D, Tarride JE, Goeree R. Canadian cost-utility analysis of initiation and maintenance treatment with anti-TNF-alpha drugs for refractory Crohn's disease. J Crohns Colitis 2012;6(1):77-85.
  3. Cogo E, Sampson M, Ajiferuke I, Manheimer E, Campbell K, Daniel R, Moher D. Searching for controlled trials of complementary and alternative medicine: a comparison of 15 databases. Evid Based Complement Alternat Med 2011;858246. Available: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137728/pdf/ECAM2011-858246.pdf.
  4. Assasi N, Blackhouse G, Xie F, Marshall JK, Irvine EJ, Gaebel K, Robertson D, Campbell K, Hopkins R, Goeree R. Patient outcomes after anti TNF-alpha drugs for Crohn's disease. Expert Rev Pharmacoecon Outcomes Res 2010;10(2):163-75.
  5. Blackhouse G, Gaebel K, Xie F, Campbell K, Assasi N, Tarride J-E, O'Reilly D, Chalk C, Levine M, Goeree R. Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada. Cost Eff Resour Alloc 2010;8(1):14. Available: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903512/pdf/1478-7547-8-14.pdf.
  6. Burke N, Whelan JP, Goeree L, Hopkins RB, Campbell K, Goeree R, Tarride J-E. Systematic review and meta-analysis of transurethral resection of the prostate versus minimally invasive procedures for the treatment of benign prostatic obstruction. Urology 2010;75(5):1015-22.
  7. Gaebel K, Blackhouse G, Campbell K, Robertson D, Xie F, Assasi N, Chalk C, Levin M, Goeree R. Intravenous immunoglobulin for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis. Open Med 2010;4(3):e154-66. Available: http://www.openmedicine.ca/article/view/337.
  8. Tarride J-E, Burke N, Bischof M, Hopkins RB, Goeree L, Campbell K, Xie F, O'Reilly D, Goeree R. A review of health utilities across conditions common in paediatric and adult populations. Health Qual Life Outcomes 2010;8:12. Available: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828427/pdf/1477-7525-8-12.pdf.
  9. Lim ME, O'Reilly D, Tarride J-E, Burke N, Ferrusi IL, Campbell K, Goeree R. Health technology assessment for radiologists: basic principles and evaluation framework. J Am Coll Radiol 2009;6(5):299-306.
  10. O'Reilly D, Campbell K, Goeree R. Basics of health technology assessment. Methods Mol Biol 2009;473:263-83.

Search for citations for Ms. Campbell on PubMed